StemCell Institute

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3399640006
JPY
844.00
11 (1.32%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
714.11
700.99
638.69
666.67
694.93
678.89
596.29
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
714.11
700.99
638.69
666.67
694.93
678.89
596.29
Raw Material Cost
274.89
268.79
245.13
249.68
253.50
238.78
235.14
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.32
1.36
1.05
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
374.11
366.90
333.88
316.23
306.94
316.54
300.56
Other Expenses
-0.13
-0.14
-0.10
0.00
0.00
0.00
0.31
Total Expenditure (Excl Depreciation)
649.00
635.69
579.00
565.91
560.44
555.31
538.76
Operating Profit (PBDIT) excl Other Income
65.1
65.3
59.699999999999996
100.8
134.5
123.6
57.5
Other Income
5.94
3.51
3.10
2.20
4.68
138.26
1.34
Operating Profit (PBDIT)
109.35
102.38
98.53
134.52
170.74
291.25
91.98
Interest
1.32
1.36
1.05
0.00
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
439.21
432.20
393.56
416.99
441.43
440.11
361.14
Depreciation
38.30
33.58
35.73
31.56
31.57
29.41
33.12
Profit Before Tax
69.72
67.45
61.75
102.96
139.17
261.84
58.86
Tax
27.94
24.34
15.89
34.98
45.58
83.47
2.86
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
41.79
43.10
45.86
67.98
93.59
178.36
56.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
41.79
43.10
45.86
67.98
93.59
178.36
56.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
41.79
43.10
45.86
67.98
93.59
178.36
56.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,608.75
2,655.20
2,627.85
2,677.11
2,870.53
2,775.14
2,692.61
Earnings per share (EPS)
4.14
4.24
4.49
6.63
9.13
17.41
5.47
Diluted Earnings per share
4.14
4.24
4.49
6.63
9.13
17.41
5.47
Operating Profit Margin (Excl OI)
9.12%
9.32%
9.35%
15.11%
19.35%
18.2%
9.65%
Gross Profit Margin
15.13%
14.41%
15.26%
20.18%
24.57%
42.9%
15.43%
PAT Margin
5.85%
6.15%
7.18%
10.2%
13.47%
26.27%
9.39%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 1.87% vs 9.75% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is -3.02% vs -6.10% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 4.55% vs 3.67% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is -7.14% vs 40.00% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of StemCell Institute With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
714.11
44.51
669.60
1,504.38%
Other Operating Income
0.00
0.00
0.00
Total Operating income
714.11
44.51
669.60
1,504.38%
Raw Material Cost
274.89
2.98
271.91
9,124.50%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.32
0.00
1.32
Selling and Distribution Expenses
374.11
123.68
250.43
202.48%
Other Expenses
-0.13
6.99
-7.12
-101.86%
Total Expenditure (Excl Depreciation)
649.00
196.57
452.43
230.16%
Operating Profit (PBDIT) excl Other Income
65.11
-152.06
217.17
142.82%
Other Income
5.94
0.03
5.91
19,700.00%
Operating Profit (PBDIT)
109.35
-149.94
259.29
172.93%
Interest
1.32
0.00
1.32
Exceptional Items
0.00
-0.39
0.39
100.00%
Gross Profit (PBDT)
439.21
41.53
397.68
957.57%
Depreciation
38.30
2.09
36.21
1,732.54%
Profit Before Tax
69.72
-152.37
222.09
145.76%
Tax
27.94
0.30
27.64
9,213.33%
Provisions and contingencies
0
0
0.00
Profit After Tax
41.79
-152.68
194.47
127.37%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
41.79
-152.68
194.47
127.37%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
41.79
-152.68
194.47
127.37%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
2,608.75
4,370.64
-1,761.89
-40.31%
Earnings per share (EPS)
4.14
-9.09
13.23
145.54%
Diluted Earnings per share
4.14
-9.09
13.23
145.54%
Operating Profit Margin (Excl OI)
9.12%
-341.66%
0.00
350.78%
Gross Profit Margin
15.13%
-337.66%
0.00
352.79%
PAT Margin
5.85%
-343.04%
0.00
348.89%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 71.41 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 1.87% vs 9.75% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 2.76% vs 9.18% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.18 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -3.02% vs -6.10% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -55.34% vs 11.30% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.34 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 4.55% vs 3.67% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -37.75% vs 5.73% in Sep 2024

Quarterly - Interest
Interest 0.13 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -7.14% vs 40.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.12%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024